Mark W Kroll Haemonetics Corp (HAE) insider trading activity

Mark W Kroll is Director of HAEMONETICS CORP. Currently has a direct ownership of 23,357 shares of HAE, which is worth approximately $1.22 Million. The most recent transaction as insider was on Jul 24, 2025, when has been sold 2,693 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K

13.03% 3M change

13.03% 12M change

Total Value Held $1.22 Million

MARK W KROLL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 24 2025	BUY Grant, award, or other acquisition	-	2,693 Added 10.34%	23,357 Common Stock
Jul 25 2024	BUY Grant, award, or other acquisition	-	2,207 Added 9.65%	20,664 Common Stock
Aug 04 2023	BUY Grant, award, or other acquisition	-	2,226 Added 10.76%	18,457 Common Stock
Aug 15 2022	SELL Open market or private sale	$590,859 $73.71 p/Share	8,016 Reduced 33.06%	16,231 Common Stock
Aug 05 2022	BUY Grant, award, or other acquisition	-	2,730 Added 10.12%	24,247 Common Stock
Aug 06 2021	BUY Grant, award, or other acquisition	-	3,077 Added 12.51%	21,517 Common Stock
May 26 2021	SELL Open market or private sale	$650,896 $55.1 p/Share	11,813 Reduced 39.05%	18,440 Common Stock
May 26 2021	BUY Exercise of conversion of derivative security	$367,532 $35.5 p/Share	10,353 Added 25.5%	30,253 Common Stock

Also insider at

AXON

AXON ENTERPRISE, INC. Industrials

MWK

Mark W Kroll

Director

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Value

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

Operation

Value

Type

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE

Account